These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 17259984)
1. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Julien SG; Dubé N; Read M; Penney J; Paquet M; Han Y; Kennedy BP; Muller WJ; Tremblay ML Nat Genet; 2007 Mar; 39(3):338-46. PubMed ID: 17259984 [TBL] [Abstract][Full Text] [Related]
2. Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Bentires-Alj M; Neel BG Cancer Res; 2007 Mar; 67(6):2420-4. PubMed ID: 17347513 [TBL] [Abstract][Full Text] [Related]
3. Estrogenic promotion of ErbB2 tyrosine kinase activity in mammary tumor cells requires activation of ErbB3 signaling. Liu B; Ordonez-Ercan D; Fan Z; Huang X; Edgerton SM; Yang X; Thor AD Mol Cancer Res; 2009 Nov; 7(11):1882-92. PubMed ID: 19861407 [TBL] [Abstract][Full Text] [Related]
4. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Zhai YF; Beittenmiller H; Wang B; Gould MN; Oakley C; Esselman WJ; Welsch CW Cancer Res; 1993 May; 53(10 Suppl):2272-8. PubMed ID: 8097963 [TBL] [Abstract][Full Text] [Related]
6. Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis. Berman-Golan D; Granot-Attas S; Elson A Cancer Metastasis Rev; 2008 Jun; 27(2):193-203. PubMed ID: 18231724 [TBL] [Abstract][Full Text] [Related]
7. Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Berman-Golan D; Elson A Oncogene; 2007 Oct; 26(49):7028-37. PubMed ID: 17486066 [TBL] [Abstract][Full Text] [Related]
8. The extracellular region of heregulin is sufficient to promote mammary gland proliferation and tumorigenesis but not apoptosis. Weinstein EJ; Leder P Cancer Res; 2000 Jul; 60(14):3856-61. PubMed ID: 10919660 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice. Zinser GM; Welsh J Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467 [TBL] [Abstract][Full Text] [Related]
10. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
11. Genetic ablation of protein tyrosine phosphatase 1B accelerates lymphomagenesis of p53-null mice through the regulation of B-cell development. Dubé N; Bourdeau A; Heinonen KM; Cheng A; Loy AL; Tremblay ML Cancer Res; 2005 Nov; 65(21):10088-95. PubMed ID: 16267035 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of the protein tyrosine phosphatase PRL-2 correlates with breast tumor formation and progression. Hardy S; Wong NN; Muller WJ; Park M; Tremblay ML Cancer Res; 2010 Nov; 70(21):8959-67. PubMed ID: 20841483 [TBL] [Abstract][Full Text] [Related]
13. Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice. Elson A Oncogene; 1999 Dec; 18(52):7535-42. PubMed ID: 10602512 [TBL] [Abstract][Full Text] [Related]
14. The role of protein tyrosine phosphatase 1B in Ras signaling. Dubé N; Cheng A; Tremblay ML Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1834-9. PubMed ID: 14766979 [TBL] [Abstract][Full Text] [Related]
17. A role for the scaffolding adapter GAB2 in breast cancer. Bentires-Alj M; Gil SG; Chan R; Wang ZC; Wang Y; Imanaka N; Harris LN; Richardson A; Neel BG; Gu H Nat Med; 2006 Jan; 12(1):114-21. PubMed ID: 16369543 [TBL] [Abstract][Full Text] [Related]
18. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types. Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070 [TBL] [Abstract][Full Text] [Related]
19. Expression of dominant-negative ErbB2 in the mammary gland of transgenic mice reveals a role in lobuloalveolar development and lactation. Jones FE; Stern DF Oncogene; 1999 Jun; 18(23):3481-90. PubMed ID: 10376526 [TBL] [Abstract][Full Text] [Related]
20. Mammary glands reconstituted with Neu/ErbB2 transformed HC11 cells provide a novel orthotopic tumor model for testing anti-cancer agents. Brandt R; Wong AM; Hynes NE Oncogene; 2001 Sep; 20(39):5459-65. PubMed ID: 11571643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]